DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Arnold D, André T, Bennouna J et al.
Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT: Results of a randomized phase III intergroup study (TML study).
J Clin Oncol 2012;
30 (suppl; abstr CRA3503)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.